Avicenna Alliance: enhanced knowledge, improved decisions, better outcomes
FULL MENU

BioTechX event, Basel

BioTechX event, Basel

28/10/2024

BACK

BioTechX event, Basel

The BioTechX event in Basel provided an excellent opportunity for the Avicenna Alliance to engage with key pharmaceutical players and discuss the growing role of in silico methods in drug discovery and development, drug delivery and manufacturing.

Thierry Marchal, President and Secretary General of the Alliance, delivered a presentation on the different levels of digital twins and their progressive adoption. He highlightedthe successful vote in the European Parliament to reference in silico methods in the Global Pharmaceutical Legislation.

He also reviewed the steps involved in achieving a personal digital avatar – a digital twin for each individual, capable of predicting and, hopefully, preventing any undesirable pathologies progression.

We greatly appreciate the excellent moderation by @Galina Boldina and are very grateful for the positive feedback from @Hélène Mouty, Johnson & Johnson.

IMAGE GALLERY:

Sign up for our monthly newsletter!

Sign up for our monthly newsletter!

Fill in the fields you find below

Avicenna Alliance is an initiative of:

Avicenna VPH

© 2018-2025 Avicenna Alliance | powered by We Berry